SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- 75N91023C00028
- Contractor
- Awarding agency
- Department of Health and Human Services
- Sub-agency / office
- National Institutes of Health
- Award amount
- $2,049,979
- Period of performance
- Sep 15, 2023 – Sep 14, 2025
- NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- PSC AN12
- Place of performance
- WA
Public award description
SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.